The Valley Desk

NCT04666610 · Interventional trial

A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

Overall registry status Completed

Phase 3

Conditions Childhood Absence Epilepsy, Juvenile Absence Epilepsy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov